Magnolia NeuroSciences Investors

17 investors on Angel Roster list Magnolia NeuroSciences in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, China and Hong Kong.

Investors are matched on the company name in their portfolio, so companies that share the name Magnolia NeuroSciences can appear together.

Investors listed
17
With verified email
53%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Magnolia NeuroSciences investors

The most complete profiles first. Showing 17 of 17.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Jieyu Zou

    Venture Capital · China

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Ling Su

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

  • Alice ChenVerified

    Accelerator · Singapore

    Health CareWellnessLife ScienceBiotechnology

    Portfolio: Magnolia NeuroSciences

    Verified email available

  • Thong LeVerified

    Accelerator · United States

    Health CareWellnessBiotechnologyNeuroscience

    Portfolio: Magnolia NeuroSciences

    Verified email available

  • Merika Koday, PhD

    Accelerator · United States

    Health CareWellnessLife ScienceBiotechnology

    Portfolio: Magnolia NeuroSciences

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Magnolia NeuroSciences investors are on Angel Roster?

Angel Roster lists 17 Magnolia NeuroSciences investors. 9 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (14), Private Equity Firms (4) and Startup Accelerators (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Magnolia NeuroSciences investors invest in?

Among those that list a stage, the most common are Series B (6).

Where are Magnolia NeuroSciences investors based?

Most are based in the United States (10), China (4) and Hong Kong (1).

Which companies have Magnolia NeuroSciences investors backed?

The most-backed portfolio companies among them are Qihan Biotech (14), Hangzhou Just Biotherapeutics (Just China) (14), Metacrine (14), KSQ Therapeutics (14) and Transcenta (14).

How do I contact Magnolia NeuroSciences investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.